These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 10861774

  • 1. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
    Cronin KA, Feuer EJ.
    Stat Med; 2000 Jul 15; 19(13):1729-40. PubMed ID: 10861774
    [Abstract] [Full Text] [Related]

  • 2. Estimating the crude probability of death due to cancer and other causes using relative survival models.
    Lambert PC, Dickman PW, Nelson CP, Royston P.
    Stat Med; 2010 Mar 30; 29(7-8):885-95. PubMed ID: 20213719
    [Abstract] [Full Text] [Related]

  • 3. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H, Bossard N, Daubisse L, Binder F, Belot A, Remontet L.
    Cancer Epidemiol; 2013 Dec 30; 37(6):857-63. PubMed ID: 24063904
    [Abstract] [Full Text] [Related]

  • 4. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
    Howlader N, Mariotto AB, Woloshin S, Schwartz LM.
    J Natl Cancer Inst Monogr; 2014 Nov 30; 2014(49):255-64. PubMed ID: 25417239
    [Abstract] [Full Text] [Related]

  • 5. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL, CONCORD Working Group.
    Lancet Oncol; 2008 Aug 30; 9(8):730-56. PubMed ID: 18639491
    [Abstract] [Full Text] [Related]

  • 6. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
    Dignam JJ, Huang L, Ries L, Reichman M, Mariotto A, Feuer E.
    Cancer; 2009 Nov 15; 115(22):5272-83. PubMed ID: 19670456
    [Abstract] [Full Text] [Related]

  • 7. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
    Brenner H, Jansen L.
    J Clin Epidemiol; 2016 Feb 15; 70():224-32. PubMed ID: 26456902
    [Abstract] [Full Text] [Related]

  • 8. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study.
    Withrow DR, Pole JD, Nishri ED, Tjepkema M, Marrett LD.
    Popul Health Metr; 2017 Jul 03; 15(1):24. PubMed ID: 28673318
    [Abstract] [Full Text] [Related]

  • 9. Noncancer deaths in white adult cancer patients.
    Brown BW, Brauner C, Minnotte MC.
    J Natl Cancer Inst; 1993 Jun 16; 85(12):979-87. PubMed ID: 8496983
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
    Brenner H, Arndt V.
    J Clin Oncol; 2005 Jan 20; 23(3):441-7. PubMed ID: 15572727
    [Abstract] [Full Text] [Related]

  • 11. [WebSurvCa: web-based estimation of death and survival probabilities in a cohort].
    Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Alarcón F, Cordero D, Díez-Villanueva A, Yasui Y, Marcos-Gragera R, Vilardell ML, Carulla M, Galceran J, Izquierdo Á, Moreno V, Borràs JM.
    Gac Sanit; 2018 Jan 20; 32(5):492-495. PubMed ID: 29357998
    [Abstract] [Full Text] [Related]

  • 12. Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.
    Sammon JD, Abdollah F, Reznor G, Pucheril D, Choueiri TK, Hu JC, Kim SP, Schmid M, Sood A, Sun M, Kibel AS, Nguyen PL, Menon M, Trinh QD.
    Eur Urol; 2015 Jul 20; 68(1):32-9. PubMed ID: 25457017
    [Abstract] [Full Text] [Related]

  • 13. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
    Feuer EJ, Lee M, Mariotto AB, Cronin KA, Scoppa S, Penson DF, Hachey M, Cynkin L, Carter GA, Campbell D, Percy-Laurry A, Zou Z, Schrag D, Hankey BF.
    Cancer; 2012 Nov 15; 118(22):5652-62. PubMed ID: 22569947
    [Abstract] [Full Text] [Related]

  • 14. The impact of state-specific life tables on relative survival.
    Stroup AM, Cho H, Scoppa SM, Weir HK, Mariotto AB.
    J Natl Cancer Inst Monogr; 2014 Nov 15; 2014(49):218-27. PubMed ID: 25417235
    [Abstract] [Full Text] [Related]

  • 15. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR, Feuer EJ, Mariotto AB.
    J Natl Cancer Inst Monogr; 2014 Nov 15; 2014(49):244-54. PubMed ID: 25417238
    [Abstract] [Full Text] [Related]

  • 16. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ.
    Eur Urol; 2011 Aug 15; 60(2):330-6. PubMed ID: 21601352
    [Abstract] [Full Text] [Related]

  • 17. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients.
    Gamel JW, Vogel RL.
    Stat Methods Med Res; 2001 Oct 15; 10(5):339-52. PubMed ID: 11697226
    [Abstract] [Full Text] [Related]

  • 18. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
    Dell'Oglio P, Bishr M, Boehm K, Trudeau V, Larcher A, Tian Z, Sosa J, Moschini M, Saad F, Capitanio U, Briganti A, Graefen M, Montorsi F, Karakiewicz PI.
    Eur Urol Focus; 2018 Dec 15; 4(6):834-841. PubMed ID: 28753853
    [Abstract] [Full Text] [Related]

  • 19. Adjusting relative survival estimates for cancer mortality in the general population.
    Ellison LF.
    Health Rep; 2014 Nov 15; 25(11):3-9. PubMed ID: 25408490
    [Abstract] [Full Text] [Related]

  • 20. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
    Dasgupta P, Cramb S, Kou K, Yu XQ, Baade PD.
    Cancer Epidemiol; 2019 Oct 15; 62():101568. PubMed ID: 31330423
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.